WCCR's Audit Service Named "Excellent Supplier" by Jingze Bio – Helped JZB30 Successfully Launch!
Published:2025-12-12 Source:Our Site Reads:133

 

Every new drug carries a solemn promise to life. Chengdu WCCR Research Center Co., Ltd. has been awarded the title of "Excellent Supplier" by Chengdu Jingze Biotechnology Co., Ltd. for its outstanding third‑party audit performance in the JZB30 project (recombinant human follicle‑stimulating hormone for injection). This recognition not only affirms our professional competence but also testifies to our quality commitment and excellence in practice.

 

From R&D to market approval, the JZB30 project faced stringent quality and compliance requirements. Independent and rigorous auditing is critical to ensuring the authenticity, integrity, and reliability of clinical trial data, as well as safeguarding study compliance and subject rights. Our audit team strictly adhered to all applicable laws, regulations, and guidelines, embedding ourselves throughout the project lifecycle:

 

• Comprehensive review of clinical trial compliance: Strict assessment of protocol execution, ethical adherence, and GCP compliance.

 

• Strict oversight of investigator qualifications and practices: Ensuring continuous alignment with protocol requirements and research qualifications.

 

• Effective protection of subject rights and safety: Monitoring informed consent processes, adverse event reporting, and other core elements.

 

With deep expertise, meticulous attitude, and extensive project experience, our audit and quality team built a solid foundation for the high‑quality advancement and successful approval of the JZB30 project. This "Excellent Supplier" award marks a milestone of close collaboration and mutual success between WCCR and Chengdu Jingze, reflecting both parties' shared commitment to quality‑first pharmaceutical R&D and patient health. It fully demonstrates that WCCR, as a trusted third‑party audit partner, can effectively help clients manage risks, improve R&D efficiency, and ensure successful registration.

 

Taking this as a new starting point, WCCR will continue to deepen strategic collaboration with partners such as Chengdu Jingze. We are dedicated to empowering more innovative drug R&D processes through professional audit services, accelerating market approval for our partners, and contributing to the high‑quality development of China's pharmaceutical industry.

 

Choose WCCR – Your Trusted Quality Guardian!

图片1.png